首页> 外国专利> CD20 Anti-CD20 Monoclonal Antibody and Tacrolimus Combination Immunosuppressive Therapy in Xenotransplantation

CD20 Anti-CD20 Monoclonal Antibody and Tacrolimus Combination Immunosuppressive Therapy in Xenotransplantation

机译:CD20抗CD20单克隆抗体和他克莫司联合免疫抑制疗法在异种移植中的应用

摘要

The present invention relates to a protocol for inhibiting an immune rejection response which may occur upon corneal xenotransplantation. According to the immune response suppression method of the present invention, not only the immune rejection by the cornea transplanted after xenotransplantation can be effectively suppressed, but also the engraftment of the cornea can be maintained stably for a long period of time and corneal thickness and intraocular pressure can be effectively maintained, thereby being usefully used for xenotransplantation.
机译:本发明涉及抑制在角膜异种移植后可能发生的免疫排斥反应的方案。根据本发明的免疫应答抑制方法,不仅可以有效地抑制异种移植后移植的角膜的免疫排斥,而且可以长期稳定地维持角膜的植入,并且角膜厚度和眼内压力可以有效地维持,从而有用地用于异种移植。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号